Vanda Pharmaceuticals Inc.

NASDAQ:VNDA

Biotechnology

Healthcare
$3.75 -3.27%

-$0.20 today

Market cap
$226.76M
Beta
0.60
P/E (TTM)
-1.4
EPS (TTM)
-$4.03
52W Low $4.14High $9.94

Volume 0.95M

Average 1.29M

Balance Sheet

Inspect the capital base behind the business.

Assets

$488.95M

FY 2025 · Annual

-25.5% YoY

Liabilities

$161.76M

FY 2025 · Annual

+37.5% YoY

Equity

$327.19M

FY 2025 · Annual

-39.2% YoY

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents52.07M135.03M135.82M102.32M84.85M
Short-term Investments380.74M331.83M252.44M272.33M179M
Net Receivables32.47M33.51M34.16M47.1M54.58M
Inventory1.02M1.19M1.36M1.73M1.85M
Other Current Assets117.73M9.17M15.42M26.99M
Total Current Assets478.3M519.29M432.95M438.89M347.26M
Property, Plant & Equipment (Net)12.39M10.97M9.14M12.68M13.51M
Goodwill00000
Intangible Assets20.08M18.57M121.37M114.1M117.09M
Long-term Investments00000
Tax Assets74.88M74.04M75M81.44M0
Other Non-current Assets8.15M11.38M9.99M9.1M11.08M
Total Non-current Assets115.49M114.96M215.49M217.31M141.69M
Total Assets593.79M634.25M648.44M656.2M488.95M
Account Payables925K12.69M7.15M3.5M4.94M
Short-term Debt00000
Tax Payables00000
Deferred Revenue00000
Other Current Liabilities27.68M34.01M69.33M69.36M87.19M
Total Current Liabilities74.42M91.44M87.7M99.98M145.16M
Long-term Debt00000
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities4.39M6.8M8.83M9.59M9.53M
Total Non-current Liabilities14.45M15.61M15.83M17.68M16.6M
Total Liabilities88.86M107.05M103.53M117.66M161.76M
Common Stock56K57K58K58K59K
Retained Earnings(164.18M)(157.9M)(155.39M)(174.29M)(394.77M)
Accumulated OCI(175K)(1.19M)(30K)74K629K
Other Stockholders Equity00000
Minority Interest00000
Total Equity504.93M527.2M544.91M538.55M327.19M
Total Debt12.37M11.14M9.4M12.36M12.62M
Net Debt(39.71M)(123.89M)(126.42M)(89.96M)(72.23M)

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$54.0M
Short-term Investments$148.3M
Receivables$56.9M
Inventory$1.7M
Other Current$32.3M
Total Current Assets$293.2M
PP&E (Net)$14.1M
Intangible Assets$115.1M
Long-term Investments$366.0K
Other Non-current$10.8M
Total Non-current Assets$140.4M
Total Assets$433.5M

Analysis

Selected assets total $433.5M for Latest. The largest visible component is Short-term Investments at $148.3M, about 34.2% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
SC 13G/ASC 13G/A filingNov 13, 2026
SC 13GSC 13G filingNov 10, 2026
4Statement of changes in beneficial ownershipNov 5, 2026
10-QQuarterly reportOct 29, 2026
8-KCurrent reportOct 28, 2026

How much cash does VNDA have?

Vanda Pharmaceuticals Inc. (VNDA) reported $84.85M in cash and equivalents in fiscal 2025.

How much debt does VNDA carry?

Vanda Pharmaceuticals Inc. (VNDA) reported $12.62M of total debt, with net debt of -$72.23M.